FDA Aims To Bolster Industry Transparency
The U.S. Food and Drug Administration has unveiled a series of plans to improve transparency in its regulation, marking its latest bid to improve compliance with agency rules governing regulated products....To view the full article, register now.
Already a subscriber? Click here to view full article